Global use of Haemophilus influenzae type b conjugate vaccine

详细信息    查看全文

• 作者：Linda R. Ojo ; Rosalyn E. O’ ; Loughlin ; Adam L. Cohen ; Jennifer D. Loo ; Karen M. Edmond ; Sharmila S. Shetty ; Allyson P. Bear ; Lois Privor-Dumm ; Ulla K. Griffiths ; Rana Hajjeh
• 关键词：Haemophilus influenzae type b ; Vaccine ; Developing countries
• 刊名：Vaccine
• 出版年：2010
• 出版时间：8 October 2010
• 年：2010
• 卷：28
• 期：43
• 页码：7117-7122
• 全文大小：477 K

文摘

Haemophilus influenzae type b (Hib) conjugate vaccines have been underutilized globally. We report progress in global use of Hib vaccines included in national immunization schedules. The number of countries using Hib vaccine increased from 89/193 (46 % ) in 2004 to 158/193 (82 % ) by the end of 2009. The increase was greatest among low-income countries eligible for financial support from the GAVI Alliance [13/75 (17 % ) in 2004, 60/72 (83 % ) by the end of 2009], and can be attributed to various factors. Additional efforts are still needed to increase vaccine adoption in lower middle income countries [20/31 (65 % ) by the end of 2009].